Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats

Diabetes

Volumn 49, Issue 4, 2000, Pages 662-666

  Evans, Terry ^a   Deng, Diana X ^a   Chen, Shali ^a   Chakrabarti, Subrata ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BOSENTAN; COLLAGEN TYPE 4; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; FIBRONECTIN; GALACTOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY BASEMENT MEMBRANE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DENSITOMETRY; DIABETES MELLITUS; DIABETIC RETINOPATHY; EXTRACELLULAR MATRIX; HOUSEKEEPING GENE; MALE; MITOGENICITY; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0034112260     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.4.662     Document Type: Article

References (40)

1. Williamson JR, Kilo C: Basement-membrane thickening and diabetic microangiopathy. Diabetes 25:925-927, 1976
2. Østerby R: Basement membrane morphology in diabetes mellitus. In Ellenberg and Rifkin's Diabetes Mellitus: Theory and Practice. Rifkin H, Porte D Jr, Eds. New York, Elsevier, 1990, p. 220-233
3. Saika S, Kawashima Y, Miyamoto T, Okada Y, Tanaka S, Yamanaka O, Ohnishi Y, Ooshima A, Yamanaka A: Immunohistochemical identification of proteoglycan types in fibrotic human capsules with intraocular lens implants. Jpn J Ophthalmol 42:368-372, 1998
4. Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M: Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 82:735-738, 1988
5. Mandarino LJ, Sundarraj N, Finlayson J, Hassell HR: Regulation of fibronectin and laminin synthesis by retinal capillary endothelial cells and pericytes in vitro. Exp Eye Res 57:609-621, 1993
6. Ayo SH, Radnik RA, Glass WF, Garoni JA, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260:F185-F191, 1991
7. Roy S, Lorenzi M: Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats. Diabetologia 39:735-738, 1996
8. Roy S, Cagliero E, Lorenzi M: Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest Ophthalmol Vis Sci 37:258-266, 1996
9. Roy S, Maiello M, Lorenzi M: Increased expression of basement membrane collagen in human diabetic retinopathy. J Clin Invest 93:438-442, 1994
10. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
11. Koya D, Jirousek MR, Lin, YW, Ishii H, Kuboki K, King GL: Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
12. Williams B, Gallacher B, Patel H, Orme C: Glucose induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 46:1497-1503, 1997
13. Levin ER: Endothelins. N Engl J Med 333:356-363, 1995
14. Levin ER: Endothelins as cardiovascular peptides. Am J Nephrol 16:246-251, 1996
15. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T: The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 86:2863-2867, 1989
16. Rubanyi GM, Polokoff MA: Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 46:325-415, 1994
17. Huggins JP, Pelton JT, Miller RC: The structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmacol Ther 59:55-123, 1993
18. Chakravarthy U, Hayes RG, Stitt AW, Douglas A: Endothelin expression in ocular tissues of diabetic and insulin-treated rats. Invest Ophthalmol Vis Sci 38:2144-2151, 1997
19. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 83:708-712, 1989
20. Takagi C, Bursell SE, Lin YW, Takagi H, Duh E, Jiang Z, Clermont AC, King GL: Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci 37:2504-2518, 1996
21. Chakrabarti S, Gan XT, Merry A, Karmazyn M, Sima AA: Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes. Curr Eye Res 17:301-307, 1998
22. Chakrabarti S, Sima AA: Endothelin-1 and endothelin-3-like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats. Diabetes Res Clin Pract 37:109-120, 1997
23. Deng DX, Evans T, Mukherjee K, Downey D, Chakrabarti S: Diabetes induced dysfunction in the retina: role of endothelins. Diabetologia 42:1228-1234, 1999
24. Evans T, Deng DX, Sima AA, Chakrabarti S: Neuronal and retinal functional abnormalities in galactosemic rats: role of endothelin-1 and its receptors (Abstract). Diabetes 47 (Suppl. 1):A143, 1998
25. Ishimura E, Shouji S, Nishizawa Y, Morii H, Kashgarian M: Regulation of mRNA expression for ECM by cultured rat mesangial cells (Abstract). J Am Soc Nephrol 2:546, 1991
26. Nakamura T, Ebihara I, Fukui M, Tomino Y, Koide H: Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli. Diabetes 44:895-899, 1995
27. Chakrabarti S, Sima AA: Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats. Diabetes 38:1181-1186, 1989
28. Chakrabarti S, Cherian PV, Sima AA: The effect of acarbose on diabetes-and age-related basement membrane thickening in retinal capillaries of the BB/W rat. Diabetes Res Clin Pract 20:123-128, 1993
29. Gundersen HJ, Jensen TB, Østerby R: Distribution of membrane thickness determined by lineal analysis. J Microsc 113:27-43, 1978
30. Jensen EB, Gundersen HJ, Østerby R: Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 115:19-33, 1979
31. Østerby R, Brekke IB, Gundersen HJ, Jorgensen HE, Lokkegaard H, Mogensen CE, Nyberg G, Parving HH, Westberg G: Quantitative studies of glomerular ultrastructure in human and experimental diabetes. Appl Pathol 2:205-211, 1984
32. Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC: Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney: elucidation of signal transduction pathways. J Clin Invest 83:336-342, 1989
33. King GL, Brownlee M: The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25:255-270, 1996
34. Roux S, Breu V, Eriel SI, Clozel M: Endothelin antagonism with bosentan: a review of potential applications. J Mol Med 77:364-376, 1999
35. Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V: The effect of an endothelin-receptor antagonist, hosentan, on blood pressure in patients with essential hypertension. New Engl J Med 338:784-790, 1998
36. Simonson MS, Jones JM, Dunn MJ: Differential regulation of fos and jun gene expression and AP-1 cis-element activity by endothelin isopeptides: possible implications for mitogenic signaling by endothelin. J Biol Chem 267:8643-8649, 1992
37. Oriji GK, Tate JE, Keiser HR: Endothelin-induced prostacyclin production in rat aortic rings is mediated by protein kinase C. Prostaglandins Leukol Essent Fatty Acids 55:309-313, 1996
38. Mitsutomi N, Akashi C, Odagiri J, Matsumura Y: Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells. Eur J Pharmacol 364:65-73, 1999
39. Hu RM, Levin ER, Pedram A, Frank HJ: Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 42:351-358, 1993
40. Nakamura T, Ebihara I, Tomino Y, Koide H: Alteration of growth-related proto-oncogene expression in diabetic glomeruli by a specific endothelin receptor A antagonist. Nephrol Dial Transplant 11:1528-1531, 1996